Orthofix Medical Income Statement (2009-2026) | OFIX

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Revenue & cost
Revenue (Quarter)	121.39M	112.43M	110.34M	92.61M	103.56M	114.00M	66.95M	162.25M	174.08M	184.01M	147.12M	175.83M	198.62M	196.61M	163.95M	181.63M	191.40M	193.81M	219.91M	186.12M
Cost of Revenue (Quarter)	27.44M	56.10M	57.10M	28.32M	31.60M	55.46M	33.05M	64.88M	67.47M	64.24M	-27.62M	61.37M	63.87M	61.55M	66.82M	72.03M	63.59M	57.11M	63.57M	57.16M
Gross Profit (Quarter)	93.95M	84.12M	91.81M	78.10M	86.47M	83.42M	89.18M	110.33M	119.55M	119.76M	136.63M	127.24M	134.75M	135.05M	148.84M	121.62M	139.53M	148.52M	156.34M	139.55M
Operating items
Amortization - Intangibles (Quarter)
Research & Development (Quarter)	13.12M	12.36M	13.24M	11.21M	12.76M	11.94M	13.15M	23.31M	19.42M	18.56M	18.94M	19.49M	18.05M	17.29M	18.81M	19.77M	15.93M	14.77M	15.37M	15.32M
Selling, General & Administrative (Quarter)	18.34M	16.31M	18.26M	19.33M	15.85M	19.32M	254.28M	48.81M	34.18M	27.14M	420.27M	131.69M	134.22M	130.14M	136.48M	132.98M	136.49M	148.10M	136.75M	134.91M
Restructuring Costs (Quarter)								18.20M	0.26M	-0.09M	1.01M	2.21M	5.35M	0.51M	1.31M
Other Operating Expenses (Quarter)				-42.60M	-0.03M	-32.50M	101.60M	0.47M	1.29M	3.85M	-20.06M	2.26M	-0.28M	8.34M	-26.09M	3.04M	4.03M	21.55M	-62.41M	2.92M
Operating Expenses (Quarter)	31.46M	28.67M	31.50M	30.54M	28.60M	31.27M	267.43M	90.32M	11.20M	9.55M	440.22M	153.39M	11.23M	10.89M	156.60M	152.75M	152.43M	162.88M	152.13M	150.23M
Operating Income (Quarter)	4.27M	-0.31M	-9.35M	-3.08M	6.64M	-5.79M	-1.49M	-59.71M	-36.63M	-24.45M	-18.32M	-29.34M	-24.91M	-18.90M	-11.48M	-48.87M	-16.00M	-17.05M	0.49M	-14.44M
EBIT (Quarter)	4.27M	-0.31M	-9.35M	-3.08M	6.64M	-5.79M	-1.49M	-59.71M	-36.63M	-24.45M	-18.32M	-29.34M	-24.91M	-18.90M	-11.48M	-48.87M	-16.00M	-17.05M	0.49M	-14.44M
Non-operating items
Non Operating Investment Income (Quarter)										0.43M	1.35M	-0.26M	1.81M	3.57M			-0.03M	-0.01M	-0.01M	-0.02M
Other Non Operating Income (Quarter)	0.95M	-1.79M	0.18M	1.24M	-3.19M	3.25M	10.73M	-0.58M	-0.27M	-2.36M	0.77M	-1.27M	0.85M	-2.53M	10.71M	1.25M	-2.75M	-0.54M	0.31M	0.90M
Non Operating Income (Quarter)	0.95M	-1.79M	0.18M	-0.94M	-3.19M	-3.31M	4.29M	0.68M	-0.02M	-2.36M	0.77M	-1.27M	-2.51M	-2.53M	-3.31M	1.25M	5.73M	-0.54M	1.67M	-0.73M
Net income details
EBT (Quarter)	4.67M	-2.54M	-2.10M	-4.39M	3.04M	-9.37M	-6.99M	-60.33M	-37.92M	-28.39M	132.75M	-35.17M	-32.36M	-26.64M	-29.71M	-52.13M	-14.22M	-22.26M	91.08M	-20.83M
Tax Provisions (Quarter)	2.25M	-0.36M	22.01M	0.07M	0.55M	1.34M	0.07M	0.61M	1.51M	0.47M	0.12M	0.85M	1.08M	0.75M	-0.56M	0.96M	-0.14M	0.53M	0.03M	0.07M
Profit After Tax (Quarter)	2.42M	-2.17M	-32.81M	-4.46M	2.49M	-10.72M	-7.06M	-60.94M	-39.43M	-28.86M	-22.17M	-36.02M	-33.44M	-27.39M	-29.15M	-53.09M	-14.08M	-22.80M	-2.22M	-20.91M
Income from Continuing Operations (Quarter)	2.42M	-2.17M	-24.11M	-4.46M	2.49M	-10.72M	-7.06M	-60.94M	-39.43M	-28.86M	132.62M	-36.02M	-33.44M	-27.39M	-29.15M	-53.09M	-14.08M	-22.80M	91.05M	-20.91M
Consolidated Net Income (Quarter)	2.42M	-2.17M	-24.11M	-4.46M	2.49M	-10.72M	-7.06M	-60.94M	-39.43M	-28.86M	132.62M	-36.02M	-33.44M	-27.39M	-29.15M	-53.09M	-14.08M	-22.80M	91.05M	-20.91M
Income towards Parent Company (Quarter)	2.42M	-2.17M	-24.11M	-4.46M	2.49M	-10.72M	-7.06M	-60.94M	-39.43M	-28.86M	132.62M	-36.02M	-33.44M	-27.39M	-29.15M	-53.09M	-14.08M	-22.80M	91.05M	-20.91M
Net Income towards Common Stockholders (Quarter)	2.42M	-2.17M	-24.11M	-4.46M	2.49M	-10.72M	-7.06M	-60.94M	-39.43M	-28.86M	132.62M	-36.02M	-33.44M	-27.39M	-29.15M	-53.09M	-14.08M	-22.80M	91.05M	-20.91M
Additional items
EPS (Basic) (Quarter)	0.12	0.11	-1.67	-0.22	0.12	-0.53	-0.35	-1.71	-1.07	-0.77	-0.59	-0.95	-0.88	-0.71	-0.75	-1.35	-0.36	-0.57	-0.05	-0.52
EPS (Weighted Average and Diluted) (Quarter)	0.12	0.11	-1.67	-0.22	0.12	-0.53	-0.35	-1.71	-1.07	-0.77	-0.59	-0.95	-0.88	-0.71	-0.75	-1.35	-0.36	-0.57	-0.05	-0.52
Shares Outstanding (Weighted Average) (Quarter)	0.02M	0.02M	19.69M	0.02M	0.02M	0.02M	20.05M	0.04M	0.04M	37.25M	36.73M	37.74M	37.79M	38.49M	38.13M	39.19M	39.50M	39.77M	39.60M	40.45M
Shares Outstanding (Diluted Average) (Quarter)
EBITDA (Quarter)	12.78M	-2.50M	-34.08M	7.11M	0.83M	14.26M	85.81M	-60.51M	21.12M	-30.61M	-210.53M	-35.39M	27.87M	-25.56M	-205.34M	-51.35M	28.92M	32.53M	37.91M	17.73M
Interest Expenses (Quarter)
Tax Rate (Quarter)	48.16%	14.36%	-1,049.50%	-1.62%	18.18%	-14.34%	-1.07%	-1.01%	-3.98%	-1.66%	0.09%	-2.42%	-3.35%	-2.82%	1.90%	-1.84%	1.00%	-2.39%	0.03%	-0.36%

Research Tools

Orthofix Medical Income Statement (2009-2026) | OFIX

Create an account

Sign In

Reset Password